Concept illustration of generative AI applied to peptide discovery

TECHNOLOGY

4 Feb 2026

Can Algorithms Outrun the Lab in Peptide Discovery?

Generative AI platforms like Menten AI’s MAUD 1.0 are speeding early peptide discovery, helping biotech firms make smarter design decision...

Prescription pill bottles and capsules representing peptide drug development

PARTNERSHIPS

3 Feb 2026

A Peptide Merger That Reflects Biotech’s New Priorities

Completed in Nov 2025, the Salarius and Decoy deal creates Decoy Therapeutics with $14M and an AI-first peptide platform

Biomedical researchers examining peptide-based implant protection methods

INSIGHTS

2 Feb 2026

A New Weapon Against Implant Infections Takes Shape

Peptide therapies advance into pivotal Phase 2/3 trials, pointing to a new way to prevent implant infections if results and approvals foll...

Pills and syringe representing competing cholesterol drug delivery methods

RESEARCH

30 Jan 2026

Can Peptide Pills Finally Challenge Cholesterol Injections?

Phase 3 data suggest oral peptide drugs could rival injectables for lowering LDL cholesterol, pointing to a future shift if approvals and ...

Lupin pharmaceutical manufacturing facility exterior with company logo

PARTNERSHIPS

27 Jan 2026

Peptide Pact Promises a Stronger Supply Chain

Lupin and PolyPeptide join forces to stabilize peptide sourcing as global demand strains supply chains

Aerial rendering of a modern drug manufacturing facility complex

INVESTMENT

26 Jan 2026

Lilly’s $6B API Bet Fuels a U.S. Peptide Race

Lilly’s Alabama investment shows how peptide capacity and reliable supply are becoming make-or-break advantages for the next wave of drugs

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.